Persistent Babesiosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Persistent Babesiosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

AVAILABLENot Applicable

NCT06478641

Expanded Use in Persistent (B. Microti) Babesiosis

The purpose of this expanded access protocol is to offer a potentially effective treatment (tafenoquine) to patients with persistent babesiosis, who have not re…

Location not specified

Treatment: Tafenoquine